loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Phenylbutazone

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Phenylbutazone

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health Canada Issues Recall of Vetoquinol N.-A. Inc Phenylbutazone Powder
    Health Canada Issues Recall of Vetoquinol N.-A. Inc Phenylbutazone Powder

    25 Sep 2019

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-vetoquinol-n-a-inc-phenylbutazone-powder-1569468790.pdf

    HEALTH CANADA
    25 Sep 2019
    Share Share
    ESTEVE and UAB Expand Their Research to Two New Gene Therapies
    ESTEVE and UAB Expand Their Research to Two New Gene Therapies

    25 Feb 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/esteve-and-uab-expand-their-research-to-two-new-gene-therapies-for-sanfilippo-b-syndrome-and-hunter-syndrome-570100801.html

    PR NEWSWIRE
    25 Feb 2016
    Share Share